Prostate Cancer Stem Cells: The Role of CD133

por Yang, Jianhui, Aljitawi, Omar, Van Veldhuizen, Peter
Publicado 2022

Circulatory MIC-1 as a Determinant of Prostate Cancer Racial Disparity

por Karan, Dev, Wick, Jo, Dubey, Seema, Tawfik, Ossama, Van Veldhuizen, Peter
Publicado 2020

DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent Pathway

por Karan, Dev, Singh, Manohar, Dubey, Seema, Van Veldhuizen, Peter J., Saunthararajah, Yogen
Publicado 2023

Gene expression profile of CD8 T cells from the responder and non-responder mice following immunotherapy treatment for prostate cancer

por Dubey, Seema, Gunewardena, Sumedha, Van Veldhuizen, Peter, Thrasher, J Brantley, Karan, Dev
Publicado 2013

Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells

por Garimella, Rama, Tadikonda, Priyanka, Tawfik, Ossama, Gunewardena, Sumedha, Rowe, Peter, Van Veldhuizen, Peter
Publicado 2017

Leukemoid reaction and autocrine growth of bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor – a potential neoplastic marker: a case repo...

por Kasi Loknath Kumar, Anup, Satyan, Megha Teeka, Holzbeierlein, Jeffrey, Mirza, Moben, Van Veldhuizen, Peter
Publicado 2014

Magmas Inhibition in Prostate Cancer: A Novel Target for Treatment-Resistant Disease

por Yang, Jianhui, Das, Bhaskar C., Aljitawi, Omar, Kumar, Avinash, Das, Sasmita, Van Veldhuizen, Peter
Publicado 2022

Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1

por Dhar, Kakali, Dhar, Gopal, Majumder, Monami, Haque, Inamul, Mehta, Smita, Van Veldhuizen, Peter J, Banerjee, Sushanta K, Banerjee, Snigdha
Publicado 2010

Emblica officinalis extract downregulates pro-angiogenic molecules via upregulation of cellular and exosomal miR-375 in human ovarian cancer cells

por De, Alok, Powers, Benjamin, De, Archana, Zhou, Jianping, Sharma, Siddarth, Van Veldhuizen, Peter, Bansal, Ajay, Sharma, Ramratan, Sharma, Mukut
Publicado 2016

The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review

por Haque, Inamul, Subramanian, Arvind, Huang, Chao H., Godwin, Andrew K., Van Veldhuizen, Peter J., Banerjee, Snigdha, Banerjee, Sushanta K.
Publicado 2017

Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis

por Haque, Inamul, Mehta, Smita, Majumder, Monami, Dhar, Kakali, De, Archana, McGregor, Douglas, Van Veldhuizen, Peter J, Banerjee, Sushanta K, Banerjee, Snigdha
Publicado 2011

Short-Term Soy Isoflavone Intervention in Patients with Localized Prostate Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

por Hamilton-Reeves, Jill M., Banerjee, Snigdha, Banerjee, Sushanta K., Holzbeierlein, Jeffrey M., Thrasher, J. Brantley, Kambhampati, Suman, Keighley, John, Van Veldhuizen, Peter
Publicado 2013

Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in (11)C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence

por Dusing, Reginald W., Peng, Warner, Lai, Sue-Min, Grado, Gordon L., Holzbeierlein, Jeffrey M., Thrasher, J. Brantley, Hill, Jacqueline, Van Veldhuizen, Peter J.
Publicado 2014

Leiomyosarcoma of the inferior vena cava: a case report and review of the literature

por Reddy, Venkataprasanth P, VanVeldhuizen, Peter J, Muehlebach, Gregory F, Dusing, Reginald W, Birkbeck, James P, Williamson, Stephen K, Krishnan, Leela, Meyers, David G
Publicado 2010

A potential regulatory loop between Lin28B:miR-212 in androgen-independent prostate cancer

por BORREGO-DIAZ, EMMA, POWERS, BENJAMIN C., AZIZOV, VUGAR, LOVELL, SCOTT, REYES, RUBEN, CHAPMAN, BRADLEY, TAWFIK, OSSAMA, McGREGOR, DOUGLAS, DIAZ, FRANCISCO J., WANG, XINKUN, VAN VELDHUIZEN, PETER
Publicado 2014

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

por Huang, Chao H., Williamson, Stephen K., Neupane, Prakash, Taylor, Sarah A., Allen, Ace, Smart, Nora J., Uypeckcuat, Adelina M., Spencer, Sarah, Wick, Jo, Smith, Holly, Van Veldhuizen, Peter J., Kelly, Karen
Publicado 2016

Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial

por Tykodi, Scott S, Gordan, Lucio N, Alter, Robert S, Arrowsmith, Edward, Harrison, Michael R, Percent, Ivor, Singal, Rakesh, Van Veldhuizen, Peter, George, Daniel J, Hutson, Thomas, Zhang, Joshua, Zoco, Jesus, Johansen, Jennifer L, Rezazadeh Kalebasty, Arash
Publicado 2022

A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer

por Huang, Chao H., Wick, Jo A., Sittampalam, Gurusingham Sitta, Nirmalanandhan, Victor Sanjit, Ganti, Apar Kishor, Neupane, Prakash C., Williamson, Stephen K., Godwin, Andrew K., Schmitt, Sarah, Smart, Nora J., Spencer, Sarah, Van Veldhuizen, Peter J.
Publicado 2014

Access to urologists for participation in research: An analysis of NCI's Community Oncology Research Program landscape survey

por Ellis, Shellie D., Vaidya, Riha, Unger, Joseph M., Stratton, Kelly, Gills, Jessie, Van Veldhuizen, Peter, Mederos, Eileen, Dressler, Emily V., Hudson, Matthew F., Kamen, Charles, Neuman, Heather B., Kazak, Anne E., Carlos, Ruth C., Weaver, Kathryn E.
Publicado 2022

Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study

por Bhatia, Shailender, Curti, Brendan, Ernstoff, Marc S, Gordon, Michael, Heath, Elisabeth I, Miller, Wilson H, Puzanov, Igor, Quinn, David I, Flaig, Thomas W, VanVeldhuizen, Peter, Byrnes-Blake, Kelly, Freeman, Jeremy A, Bittner, Rachel, Hunder, Naomi, Souza, Sonia, Thompson, John A
Publicado 2014